Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
Taylor Morrison Home
TMHC
KB Home
KBH
US Stock MarketDetailed Quotes
TGTX TG Therapeutics
- 39.860
- -0.340-0.85%
Close Mar 28 16:00 ET
- 39.882
- +0.022+0.05%
Post 20:01 ET
6.26BMarket Cap265.73P/E (TTM)
40.560High38.780Low1.64MVolume40.200Open40.200Pre Close64.93MTurnover1.12%Turnover Ratio265.73P/E (Static)157.07MShares43.32052wk High28.15P/B5.83BFloat Cap12.93052wk Low--Dividend TTM146.38MShs Float149414.006Historical High--Div YieldTTM4.43%Amplitude0.956Historical Low39.505Avg Price1Lot Size
TG Therapeutics News
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HUME DANIEL
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 10-K: FY2024 Annual Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEISS MICHAEL S
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | 8-K: Current report
TG Therapeutics | SCHEDULE 13G/A: Others
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Darwin Global Management, Ltd.(0%),Dr. Abhishek Trehan(0%), etc.
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 144/A: Others
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann
TG Therapeutics | 10-Q: Q3 2024 Earnings Report
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.